12
Participants
Start Date
October 31, 2014
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
Long-acting injectable naltrexone
Vivitrol is a long-acting opioid antagonist which blocks opioid agonists from binding at opioid receptors. It be administered as described above.
STARS Downtown, Columbia-Presbyterian and New York State Psychiatric Institute, New York
STARS clinic, Columbia-New York Presbyterian and New York State Psychiatric Institute, New York
New York State Psychiatric Institute
OTHER